IL-36γ may, therefore, drive COPD pathophysiology via the recruitment and activation of neutrophils into the lung, leading to small airway remodeling, emphysema, and mucus hypersecretion (Figure 10). The gene discussed is IL36G; the disease is pulmonary emphysema.